References
- Jain RK. Determinants of tumor blood flow: A review. Cancer Res 1988;48:2641–58.
- Steel GG. Growth kinetics of tumors. Oxford UK: Clarendon Press; 1977.
- Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Res 1989;49:6449–65.
- Fenton BM, Kiani MF, Siemann DW. Should direct measurements of tumor oxygenation relate to the radiobiological hypoxic fraction of a tumor? Int J Radiat Oncol Biol Phys 1995;33:365–73.
- Verheij M. Clinical biomarkers and imaging for radiotherapy-induced cell death. Cancer Metastasis Rev 2008;27: 471–80.
- Toms AP, White LM, Kandel R, Bleakney RR, Noseworthy M, Lee S, . Limitations of single slice dynamic contrast enhanced MR in pharmacokinetic modeling of bone sarcomas. Acta Radiol 2009;50:512–20.
- Jakobsen I, Kaalhus O, Lyng H, Rofstad EK. Detection of necrosis in human tumour xenografts by proton magnetic resonance imaging. Br J Cancer 1995;71:456–61.
- Vossen JA, Buijs M, Geschwind JF, Liapi E, Prieto V, Lee KH, . Diffusion-weighted and Gd-EOB-DTPA-contrast-enhanced magnetic resonance imaging for characterization of tumor necrosis in an animal model. J Comput Assist Tomogr 2009;33:626–30.
- Kettelhack C, Wickede M, Vogl T, Schneider U, Hohenberger P. 31Phosphorus-magnetic resonance spectroscopy to assess histologic tumor response noninvasively after isolated limb perfusion for soft tissue tumors. Cancer 2002;94:1557–64.
- Bremer C, Bankert J, Filler T, Ebert W, Tombach B, Reimer P. High-dose Gd-DTPA vs. Bis-Gd-mesoporphyrin for monitoring laser-induced tissue necrosis. J Magn Reson Imaging 2005;21:801–8.
- Metz S, Daldrup-Unk HE, Richter T, Räth C, Ebert W, Settles M, . Detection and quantification of breast tumor necrosis with MR imaging: Value of the necrosis-avid contrast agent Gadophrin-3. Acad Radiol 2003;10:484–90.
- Benjaminsen IC, Graff BA, Brurberg KG, Rofstad EK. Assessment of tumor blood perfusion by high-resolution dynamic contrast-enhanced MRI: A preclinical study of human melanoma xenografts. Magn Reson Med 2004;52: 269–76.
- Graff BA, Benjaminsen IC, Brurberg KG, Ruud EBM, Rofstad EK. Comparison of tumor blood perfusion assessed by dynamic contrast-enhanced MRI with tumor blood supply assessed by invasive imaging. J Magn Reson Imaging 2005;21:272–81.
- Vestvik IK, Egeland TA, Gaustad JV, Mathiesen B, Rofstad EK. Assessment of microvascular density, extracellular volume fraction, and radiobiological hypoxia in human melanoma xenografts by dynamic contrast-enhanced MRI. J Magn Reson Imaging 2007;26:1033–42.
- Benjaminsen IC, Brurberg KG, Ruud EBM, Rofstad EK. Assessment of extravascular extracellular space fraction in human melanoma xenografts by DCE-MRI and kinetic modeling. Magn Reson Imaging 2008;26:160–70.
- Egeland TAM, Simonsen TG, Gaustad JV, Gulliksrud K, Ellingsen C, Rofstad EK. Dynamic contrast-enhanced magnetic resonance imaging of tumors: Preclinical validation of parametric images. Radiat Res 2009;172:339–47.
- Egeland TAM, Gaustad JV, Benjaminsen IC, Hedalen K, Mathiesen B, Rofstad EK. Assessment of fraction of hypoxic cells in human tumor xenografts with necrotic regions by dynamic contrast-enhanced MRI. Radiat Res 2008;169:689–99.
- Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, . Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: Standardized quantities and symbols. J Magn Reson Imaging 1999;10:223–32.
- Hittmair K, Gomiscek G, Langenberger K, Recht M, Imhof H, Kramer J. Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI. Magn Reson Med 1994;31:567–71.
- Mayr NA, Yuh WT, Arnholt JC, Ehrhardt JC, Sorosky JI, Magnotta VA, . Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer. J Magn Reson Imaging 2000;12:1027–33.
- Loncaster JA, Carrington BM, Sykes JR, Jones AP, Todd SM, Cooper R, . Prediction of radiotherapy outcome using dynamic contrast-enhanced MRI of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2002;54:759–67.
- Morgan B, Utting JF, Higginson A, Thomas AL, Steward WP, Horsfield MA. A simple, reproducible method for monitoring the treatment of tumours using dynamic contrast-enhanced MR imaging. Br J Cancer 2006;94:1420–7.
- Nielsen T, Murata R, Maxwell RJ, Stødkilde-Jørgensen H, Østergaard L, Horsman MR. Preclinical studies to predict efficacy of vascular changes induced by combretastatin A-4 disodium phosphate in patients. Int J Radiat Oncol Biol Phys 2008;70:859–66.
- Viertl D, Delaloye AB, Lanz B, Poitry-Yamate C, Gruetter R, Mlynarik V, . Increase of [18F]FLT tumor uptake in vivo mediated by FdUrd: Toward improving cell proliferation positron emission tomography. Mol Imaging Biol 2010, June 16 [Epub ahead of print]. DOI: 10.1007/s11307-010-0368-z.
- Mima K, Hirota M, Abe S, Iwatsuki M, Imamura H, Tsuruzoe S, . Small solid pseudopapillary tumor of the pancreas in a 32-year-old man: Report of a case. Surg Today 2010;40:772–6.
- DeJordy JO, Bendel P, Horowitz A, Salomon Y, Degani H. Correlation of MR imaging and histologic findings in mouse melanoma. J Magn Reson Imaging 1992;2:695–700.
- Lyng H, Haraldseth O, Rofstad EK. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 2000;43:828–36.